salutedomani.com
-
Showing posts tagged fda
-
FDA approves Ferriprox to treat patients with excess iron in the body
The U.S. Food and Drug Administration approved Ferriprox (deferiprone) to treat patients with iron overload due to blood transfusions in patients with thalassemia, a genetic blood disorder that causes anemia, who had an inadequate response to prior chelation therapy.
-
FDA, ‘Lucky 13’ Tips for a Safe Halloween
Whether you’re goblin or ghoul, vampire or witch, poor costume choices—including decorative contact lenses and flammable costumes—and face paint allergies can haunt you long after Halloween if they cause injury.
Enjoy a safe and happy Halloween by following the “lucky 13” guidelines from FDA, the Consumer Product Safety Commission, and the Centers for Disease Control and Prevention:
-
Halloween, Black Licorice: Trick or Treat?
As it turns out, you really can overdose on candy—or, more precisely, black licorice.
Days before the biggest candy eating holiday of the year, the Food and Drug Administration (FDA) encourages moderation if you enjoy snacking on the old fashioned favorite.
(Source: salutedomani.com)
-
FDA invests $2 million in partnerships through Centers of Excellence in Regulatory Science and Innovation
The U.S. Food and Drug Administration today announced the award of $2 million to support two regional Centers of Excellence in Regulatory Science and Innovation (CERSI).
-
FDA approves system to repair abdominal aneurysms in people with small arteries
The U.S. Food and Drug Administration has approved a stent graft system that provides patients with small arteries the option of less invasive surgery to repair their potentially life-threatening abdominal aortic aneurysm.
-
FDA approves Xarelto to prevent stroke in people with common type of abnormal heart rhythm
The U.S. Food and Drug Administration approved the anti-clotting drug Xarelto (rivaroxaban) to reduce the risk of stroke in people who have abnormal heart rhythm (non-valvular atrial fibrillation). Atrial fibrillation occurs in more than 2 million Americans and is one of the most common types of abnormal heart rhythm.
-
FDA approves Erbitux* (cetuximab) to treat late-stage head and neck cancer
The U.S. Food and Drug Administration approved Erbitux (cetuximab) for use with chemotherapy to treat patients with late-stage (metastatic) head and neck cancer.
-
FDA approves first cord blood product
The U.S. Food and Drug Administration approved HEMACORD, the first licensed hematopoietic progenitor cells-cord (HPC-C) cell therapy.
(Source: salutedomani.com)
-
FDA approves Jakafi (ruxolitinib), first drug to treat a rare bone marrow disease
The U.S. Food and Drug Administration approved Jakafi (ruxolitinib), the first drug approved to specifically treat patients with the bone marrow disease myelofibrosis.
(Source: salutedomani.com)
